147
Views
29
CrossRef citations to date
0
Altmetric
Meeting Report

Global antimicrobial resistance: from surveillance to stewardship. Part 1: surveillance and risk factors for resistance

&
Pages 1269-1271 | Published online: 10 Jan 2014

References

  • Badal R, Lob S, Bouchillon S et al. Global trends in frequency and susceptibility of extended-spectrum β-lactamase positive E. coli, K. Pneumoniae, and K. oxytoca isolated from intra-abdominal infections since 2005 – the SMART Study. Presented at: The 22nd European Congress of Clinical Microbiology and Infectious Diseases. London, UK, 31 March–3 April 2012 (Poster 1179).
  • Badal R, Lob S, Bouchillon S et al. Susceptibility of intra-abdominal pathogens in Europe, Africa and the Middle East – SMART 2010/2011. Presented at: The 22nd European Congress of Clinical Microbiology and Infectious Diseases. London, UK, 31 March–3 April 2012 (Poster 1181).
  • Badal R, Lob S, Bouchillon S et al. Susceptibility of intra-abdominal pathogens and occurrence of extended-spectrum β-lactamase producers in 13 European countries – the SMART study 2010–2011. Presented at: The 22nd European Congress of Clinical Microbiology and Infectious Diseases. London, UK, 31 March–3 April 2012 (Poster 1180).
  • Badal R, Bouchillon S, Hoban D, Hackel M. Comparative in vitro activity of amoxicillin/clavulanate against aerobic Gram-negative pathogens in Spain – SMART 2005–2012. Presented at: The 22nd European Congress of Clinical Microbiology and Infectious Diseases. London, UK, 31 March–3 April 2012 (Poster 1184).
  • Woodford N. Current epidemiology of OXA carbapenemases in Klebsiella. Clin. Microbiol. Infect. 18(Suppl. S3), S492 (2012).
  • Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerging Infect. Dis. 17(10), 1791–1798 (2011).
  • Cuzon G, Naas T, Truong H et al. Worldwide diversity of Klebsiella pneumoniae that produce β-lactamase blaKPC-2 gene. Emerging Infect. Dis. 16(9), 1349–1356 (2010).
  • Cantón R, Akóva M, Carmeli Y et al.; European Network on Carbapenemases. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin. Microbiol. Infect. 18(5), 413–431 (2012).
  • Curiao T, Morosini MI, Ruiz-Garbajosa P et al. Emergence of bla KPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain. J. Antimicrob. Chemother. 65(8), 1608–1614 (2010).
  • Patel N, Harrington S, Dihmess A et al. Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae. J. Antimicrob. Chemother. 66(7), 1600–1608 (2011).
  • Kritsotakis EI, Tsioutis C, Roumbelaki M, Christidou A, Gikas A. Antibiotic use and the risk of carbapenem-resistant extended-spectrum-β-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case–control study. J. Antimicrob. Chemother. 66(6), 1383–1391 (2011).
  • Ludden C, Boyle F, Hanahoe B et al. Clonal group 025b-ST131 accounts for more than 89% of clinical isolates of ESBL-producing E. coli from hospital and nursing homes in one region of Ireland. Presented at: The 22nd European Congress of Clinical Microbiology and Infectious Diseases. London, UK, 31 March–3 April 2012 (Poster 1520).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.